UPDATE 2-ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPO

2

(Adds analyst comments in paragraph 5, 9 and 10) By Pragyan Kalita Sept 25 (Reuters) – Shares of ADARx Pharmaceuticals rose 30% above their initial public offering price on Friday after the late-stage

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)